Synthesis and evaluation of non-hydrolyzable D-mannose 6-phosphate surrogates reveal 6-deoxy-6-dicarboxymethyl-D-mannose as a new strong inhibitor of phosphomannose isomerases. 2009

Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
Univ Paris-Sud, Equipe de Chimie Bioorganique et Bioinorganique, ICMMO, UMR8182, Bâtiment 420, 15 rue Georges Clemenceau, Orsay F-91405, France.

Non-hydrolyzable d-mannose 6-phosphate analogues in which the phosphate group was replaced by a phosphonomethyl, a dicarboxymethyl, or a carboxymethyl group were synthesized and kinetically evaluated as substrate analogues acting as potential inhibitors of type I phosphomannose isomerases (PMIs) from Saccharomyces cerevisiae and Escherichia coli. While 6-deoxy-6-phosphonomethyl-d-mannose and 6-deoxy-6-carboxymethyl-D-mannose did not inhibit the enzymes significantly, 6-deoxy-6-dicarboxymethyl-D-mannose appeared as a new strong competitive inhibitor of both S. cerevisiae and E. coli PMIs with K(m)/K(i) ratios of 28 and 8, respectively. We thus report the first malonate-based inhibitor of an aldose-ketose isomerase to date. Phosphonomethyl mimics of the 1,2-cis-enediolate high-energy intermediate postulated for the isomerization reaction catalyzed by PMIs were also synthesized but behave as poor inhibitors of PMIs. A polarizable molecular mechanics (SIBFA) study was performed on the complexes of d-mannose 6-phosphate and two of its analogues with PMI from Candida albicans, an enzyme involved in yeast infection homologous to S. cerevisiae and E. coli PMIs. It shows that effective binding to the catalytic site occurs with retention of the Zn(II)-bound water molecule. Thus the binding of the hydroxyl group on C1 of the ligand to Zn(II) should be water-mediated. The kinetic study reported here also suggests the dianionic character of the phosphate surrogate as a likely essential parameter for strong binding of the inhibitor to the enzyme active site.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008359 Mannose-6-Phosphate Isomerase An enzyme that catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate, an important step in glycolysis. EC 5.3.1.8. Mannosephosphate Isomerase,Phosphomannose Isomerase,Isomerase, Mannose-6-Phosphate,Isomerase, Mannosephosphate,Isomerase, Phosphomannose,Mannose 6 Phosphate Isomerase
D008360 Mannosephosphates Phosphoric acid esters of mannose.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
February 2001, Carbohydrate research,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
December 2002, Bioorganic & medicinal chemistry,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
April 2008, Chemistry & biodiversity,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
January 2016, Bioorganic & medicinal chemistry letters,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
May 2009, Carbohydrate research,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
July 2011, Carbohydrate research,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
August 1986, Carbohydrate research,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
December 1998, Bioorganic & medicinal chemistry letters,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
March 1972, Carbohydrate research,
Johanna Foret, and Benoit de Courcy, and Nohad Gresh, and Jean-Philip Piquemal, and Laurent Salmon
June 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!